Factories For Sale As Roche's Modernization Drives Site Closures
This article was originally published in Scrip
Roche Holding AG will cease manufacturing at four sites in Europe and the US in a modernizing move that could see up to 1,200 jobs lost as a result of changes in the cancer specialist's portfolio of therapies. The decision follows a review of Roche's global manufacturing network for small molecules and an assessment of future drug innovation patterns.
Register for our free email digests: